Otsikko Julkaisija Vuosi Info
The Effect of Leukocyte Concentration on Platelet-Rich Plasma Injections for Knee Osteoarthritis Aazad Abbas, HBSc Jin Tong Du, BMSc Herman S. Dhotar, MD, MPH, FRCSC 2022 JBJS, March 16, 2022, Volume 104, Issue 6 Open
Rich or Poor? Examining Platelet-Rich Plasma Leukocyte Concentration in Knee Osteoarthritis Evan E. Vellios, MD 2022 JBJS, March 16, 2022, Volume 104, Issue 6 Open
Integrating the Combined Sagittal Index Reduces the Risk of Dislocation Following Total Hip Replacement George Grammatopoulos, BSc, MBBS, DPhil(Oxon), FRCS(Tr&Orth) Amedeo Falsetto, MD, FRCSC Ethan Sanders, BSc, MD Johannes Weishorn, MD Harinderjit S. Gill, BEng, DPhil, FIPEM Paul E. Beaulé, MD, FRCSC Moritz M. Innmann, MD, PhD Christian Merle, MD, MSc 2022 JBJS, March 2, 2022, Volume 104, Issue 5 Open
Oral and IV Antibiotic Administration After Single-Stage Revision Shoulder Arthroplasty Jie J. Yao, MD Kevin Jurgensmeier, BS Anastasia J. Whitson, BSPH Paul S. Pottinger, MD Frederick A. Matsen, III, MD Jason E. Hsu, MD 2022 JBJS, March 2, 2022, Volume 104, Issue 5 Open
Factors Affecting the Risk of Aseptic Patellar Complications in Primary TKA Performed with Cemented All-Polyethylene Patellar Resurfacing Afton K. Limberg, BS Meagan E. Tibbo, MD Matthieu Ollivier, MD Nattapol Tammachote, MD, MS Matthew P. Abdel, MD Daniel J. Berry, MD 2022 JBJS, March 2, 2022, Volume 104, Issue 5 Open
Variation in the Profit Margin for Different Types of Total Joint Arthroplasty Christopher J. Fang, MD Jonathan M. Shaker, MS Paul-Anthony Hart, BA Charles Cassidy, MD David A. Mattingly, MD Andrew Jawa, MD Eric L. Smith, MD 2022 JBJS, March 2, 2022, Volume 104, Issue 5 Open
PLAN and AM-PAC “6-Clicks” Scores to Predict Discharge Disposition After Primary Total Hip and Knee Arthroplasty Matthew J. Hadad, MD Melissa N. Orr, BS Ahmed K. Emara, MD Alison K. Klika, MS Joshua K. Johnson, DPT, PhD Nicolas S. Piuzzi, MD 2022 JBJS, February 2, 2022, Volume 104, Issue 3  Open
Defining the Patient Acceptable Symptom State for the HOOS JR and KOOS JR After Primary Total Joint Arthroplasty Kyle N. Kunze, MD Mark A. Fontana, PhD Catherine H. MacLean, MD, PhD Stephen Lyman, PhD Alexander S. McLawhorn, MD, MBA 2022 JBJS, February 2, 2022, Volume 104, Issue 3  Open
In Patients with Periprosthetic Joint Infection Treated with Surgery, Antibiotic Therapy for 6 Versus 12 Weeks After Surgery Increased Persistent Infection at 2 Years Javad Parvizi, MD, FRCS 2022 JBJS, February 2, 2022, Volume 104, Issue 3 Open
Objective Assessment Scores and the Development of Efficient Health-Care Systems in Arthroplasty Amit Meena, MBBS, MS, DNB 2022 JBJS, February 2, 2022, Volume 104, Issue 3  Open
Sex Differences in End-Stage Ankle Arthritis and Following Total Ankle Replacement or Ankle Arthrodesis Andrew Dodd, MD, FRCSC Ellie Pinsker, PhD Alastair S.E. Younger, MBChB, ChM, FRCSC Murray J. Penner, MD, FRCSC Kevin J. Wing, MD, FRCSC Peter J. Dryden, MSc, MD, FRCSC Mark Glazebrook, MSc, PhD, MD, FRCSC Timothy R. Daniels, MD, FRCSC 2022 JBJS, February 2, 2022, Volume 104, Issue 3  Open
Redefining the 3D Topography of the Acetabular Safe Zone Mario Hevesi, MD, PhD Cody C. Wyles, MD Pouria Rouzrokh, MD, MPH, MHPE Bradley J. Erickson, MD, PhD Hilal Maradit-Kremers, MD David G. Lewallen, MD Michael J. Taunton, MD Robert T. Trousdale, MD Daniel J. Berry, MD 2022 JBJS, February 2, 2022, Volume 104, Issue 3  Open
National Trends in Post-Acute Care Costs Following Total Hip Arthroplasty from 2010 through 2018 Joseph Serino, III, MD Robert A. Burnett, III, MD Craig J. Della Valle, MD P. Maxwell Courtney, MD 2022 JBJS, February 2, 2022, Volume 104, Issue 3  Open
Development and Internal Validation of Machine Learning Algorithms for Predicting Hyponatremia After TJA Kyle N. Kunze, MD Peter K. Sculco, MD Haoyan Zhong, MPA Stavros G. Memtsoudis, MD, PhD, MBA Michael P. Ast, MD Thomas P. Sculco, MD Kethy M. Jules-Elysee, MD 2022 JBJS, February 2, 2022, Volume 104, Issue 3  Open
What’s New in Adult Reconstructive Knee Surgery Jesus M. Villa, MD Tejbir S. Pannu, MD, MS Carlos A. Higuera-Rueda, MD 2022 JBJS, January 19, 2022, Volume 104, Issue 2 Open
Patients Who Do Not Receive Aspirin Because of Allergy Have an Increased Risk of Venous Thromboembolism Following Total Joint Arthroplasty Graham S. Goh, MD Elie Kozaily, MD Timothy L. Tan, MD Javad Parvizi, MD, FRCS 2022 JBJS, January 19, 2022, Volume 104, Issue 2 Open
Does Total Hip Arthroplasty Influence the Development and Localization of Sacral Insufficiency Fractures? Isabel Graul, MD Patrick Strube, MD Sophia Vogt, MD Georg Matziolis, MD Steffen Brodt, MD Alexander Hölzl, MD 2022 JBJS, January 19, 2022, Volume 104, Issue 2 Open
Effect of Sequential Intravenous and Oral Tranexamic Acid on Hemoglobin Drop After Total Knee Arthroplasty Moon Jong Chang, MD, PhD Joung Youp Shin, MD Chan Yoon, MD, MS Tae Woo Kim, MD, PhD Chong Bum Chang, MD, PhD Seung-Baik Kang, MD, PhD 2022 JBJS, January 19, 2022, Volume 104, Issue 2 Open
Inflammatory Bowel Diseases Increase the Risk of Periprosthetic Joint Infection Emanuele Chisari, MD Darren D’Mello, BA Matthew B. Sherman, BS Javad Parvizi, MD, FRCS 2022 JBJS, January 19, 2022, Volume 104, Issue 2 Open
Predictors and Outcomes of Postoperative Hemoglobin of <8 g/dL in Total Joint Arthroplasty Yash P. Chaudhry, DO Aoife MacMahon, MD Sandesh S. Rao, MD Kevin L. Mekkawy, DO Gregory R. Toci, BS Julius K. Oni, MD Robert S. Sterling, MD Harpal S. Khanuja, MD 2022 JBJS, January 19, 2022, Volume 104, Issue 2 Open
The Effect of Surgical Approach and Femoral Prosthesis Type on Revision Rates Following Total Hip Arthroplasty Wayne Hoskins, MBBS(Hons), FRACS, PhD Sophia Rainbird, PhD Yi Peng, Med(Epi&Stats) Stephen E. Graves, MBBS, DPhil(Oxon), FRACS(Orth), FAOrthA Roger Bingham, MBBS, FRACS 2022 JBJS, January 5, 2022, Volume 104, Issue 1 Open
Moxifloxacin Concentrations in the Knee Joint, Tibial Bone, and Soft Tissue When Combined with Rifampicin Josefine Slater, MD Maiken Stilling, MD, PhD Pelle Hanberg, MD, PhD Mathias Alrø Fichtner Bendtsen, BSc Andrea René Jørgensen, MD Kjeld Søballe, MD, DMSc Nis Pedersen Jørgensen, MD, PhD Mats Bue, MD, PhD 2022 JBJS, January 5, 2022, Volume 104, Issue 1 Open
Lymphedema Is a Significant Risk Factor for Failure After Primary Total Hip Arthroplasty William G. Rainer, DO Joshua M. Kolz, MD Cody C. Wyles, MD Matthew T. Houdek, MD Kevin I. Perry, MD David G. Lewallen, MD 2022 JBJS, January 5, 2022, Volume 104, Issue 1 Open
Shared Decision-Making Is Associated with Better Outcomes in Patients with Knee But Not Hip Osteoarthritis Karen R. Sepucha, PhD Ha Vo, MPH Yuchiao Chang, PhD Janet M. Dorrwachter, CNP, DNP Maureen Dwyer, PhD, ATC Andrew A. Freiberg, MD Carl T. Talmo, MD Hany Bedair, MD 2022 JBJS, January 5, 2022, Volume 104, Issue 1 Open
Development of a Knee Arthroplasty Episode-Based Cost Measure for Evaluating Cost in the Merit-Based Incentive Payment System Nirmal Choradia, MD Joyce Lam, MPP Binglie Luo Sam Bounds Adolph J. Yates, Jr., MD Juan Quintana, DNP, MHS, CRNA Rose Do, MD Laurie Feinberg, MD Alex Sandhu, MD, MS Daniel Vail, MD Tom MaCurdy, PhD Sriniketh Nagavarapu, PhD Jay Bhattacharya, MD, PhD on behalf of , and the Knee Arthroplasty Workgroup 2022 JBJS, January 5, 2022, Volume 104, Issue 1 Open

Tilaa uutiskirje